ATE407685T1 - Verbindungen und methoden zur behandlung von hautverletzungen - Google Patents

Verbindungen und methoden zur behandlung von hautverletzungen

Info

Publication number
ATE407685T1
ATE407685T1 AT01984214T AT01984214T ATE407685T1 AT E407685 T1 ATE407685 T1 AT E407685T1 AT 01984214 T AT01984214 T AT 01984214T AT 01984214 T AT01984214 T AT 01984214T AT E407685 T1 ATE407685 T1 AT E407685T1
Authority
AT
Austria
Prior art keywords
skin
appearance
compounds
methods
subject
Prior art date
Application number
AT01984214T
Other languages
English (en)
Inventor
Timothy Rayner
Allison Cowin
David Belford
Original Assignee
Novozymes Biopharma Au Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes Biopharma Au Ltd filed Critical Novozymes Biopharma Au Ltd
Application granted granted Critical
Publication of ATE407685T1 publication Critical patent/ATE407685T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Obesity (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
AT01984214T 2000-07-13 2001-07-13 Verbindungen und methoden zur behandlung von hautverletzungen ATE407685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ8786A AUPQ878600A0 (en) 2000-07-13 2000-07-13 Compositions and methods for the treatment of intact skin

Publications (1)

Publication Number Publication Date
ATE407685T1 true ATE407685T1 (de) 2008-09-15

Family

ID=3822850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01984214T ATE407685T1 (de) 2000-07-13 2001-07-13 Verbindungen und methoden zur behandlung von hautverletzungen

Country Status (9)

Country Link
US (1) US7410946B2 (de)
EP (1) EP1303284B1 (de)
JP (1) JP2004502788A (de)
AT (1) ATE407685T1 (de)
AU (1) AUPQ878600A0 (de)
CA (1) CA2415701A1 (de)
DE (1) DE60135755D1 (de)
NZ (1) NZ523533A (de)
WO (1) WO2002005828A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134780A1 (en) * 2001-10-05 2003-07-17 Procyte Corporation Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof
KR20050033510A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 피부의 색소 과다 침착의 치료방법
AUPS282002A0 (en) * 2002-06-06 2002-06-27 Gropep Limited Metalloproteinase inhibitors
WO2004004671A1 (en) * 2002-07-02 2004-01-15 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
KR100980352B1 (ko) * 2003-05-07 2010-09-06 유키지루시 뉴교 가부시키가이샤 피부 콜라겐 생성 촉진제
IL157814A (en) 2003-09-08 2007-12-03 Lev Bar Ltd Cosmetic composition comprising camel milk or components thereof
US20070275084A1 (en) * 2003-11-21 2007-11-29 Grigg Geoffrey W Compositions And Methods For The Treatment Of Skin Damage
DE102005002486A1 (de) * 2005-01-18 2006-07-27 Henkel Kgaa Tensidhaltiges Reinigungsmittel mit speziellen Proteinen
CA2602612A1 (en) * 2005-04-04 2006-10-12 Bioartificial Gel Technologies Inc. Prevention and treatment of radiation dermatitis
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US7776339B2 (en) * 2006-01-11 2010-08-17 Active Organics, Lp Extract of R. miehei
JP2008255020A (ja) * 2007-04-02 2008-10-23 Fujifilm Corp 抗老化皮膚外用剤
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
AU2010258223B2 (en) * 2009-06-09 2014-12-04 Ramot At Tel-Aviv University Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
US8100186B2 (en) * 2009-07-15 2012-01-24 Enventure Global Technology, L.L.C. Expansion system for expandable tubulars and method of expanding thereof
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
CA2823505A1 (en) * 2011-01-26 2012-08-02 Megmilk Snow Brand Co., Ltd. Agent for improving peripheral sensitivity of skin
US20140234433A1 (en) * 2013-02-15 2014-08-21 Nicholas V. Perricone Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin
CN104547309A (zh) * 2014-12-25 2015-04-29 湖南炎帝生物工程有限公司 一种祛黄褐斑的中药组合物及其制备方法与应用
CN105396124A (zh) * 2015-11-30 2016-03-16 吉林省宝沪生物科技有限公司 一种治疗紫外线致表皮角朊细胞凋亡的药物
RU2632707C1 (ru) * 2016-12-07 2017-10-09 Лариса Валентиновна Гладских Способ профилактики реинфицирования травмированной поверхности кожи у пациентов при проведении косметической процедуры пилинга
CN106906180A (zh) * 2016-12-28 2017-06-30 里程 一种具有生物活化作用的复合添加剂及其制备方法和用途
CN107397862A (zh) * 2017-08-24 2017-11-28 王小军 一种治疗坏疽性脓皮症的中药
CN111704652B (zh) * 2020-06-02 2022-04-22 昆明医科大学 一种抗光损伤皮肤保护活性多肽om-gl15及其应用
CN112221021B (zh) * 2020-11-02 2023-02-07 中南大学湘雅三医院 一种皮肤科智能激光祛斑控制系统
KR102627823B1 (ko) * 2021-05-11 2024-01-19 충북대학교 산학협력단 우유로부터 유래된 엑소좀을 유효성분으로 포함하는 흉터 생성 억제용 조성물
CN113312790A (zh) * 2021-06-16 2021-08-27 中国医学科学院放射医学研究所 一种辐射剂量的分析方法、装置、存储介质及电子设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959491A (en) * 1974-10-29 1976-05-25 Stiefel Laboratories, Inc. Stable human skin cosmetic composition containing milk
US6319522B1 (en) * 1990-07-13 2001-11-20 Gropep Limited Growth-promoting agent
ES2236681T3 (es) * 1990-07-13 2005-07-16 Gropep Limited Agente promotor de crecimiento.
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
ES2102813T3 (es) * 1993-01-26 1997-08-01 Horse Vitality Ltd Composiciones farmaceuticas y dermocosmeticas que contienen calostro equino.
US5435997A (en) * 1994-02-08 1995-07-25 Burns; Michael J. Topical agent and method for the treatment of pseudofolliculitis barbae
AUPM534794A0 (en) * 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor
JPH08133943A (ja) * 1994-11-04 1996-05-28 Kyodo Nyugyo Kk 美肌剤
DE59712305D1 (de) * 1996-03-15 2005-06-16 Bioequal Ag Muttenz Verfahren zur gewinnung eines komplexes aus wachstumsfaktoren
DE19649891C2 (de) 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
ES2139525B1 (es) * 1997-11-17 2000-10-16 Sanchez Pedro Cuevas Empleo de derivados del lactosuero como citoprotectores y cicatrizantes.
JP3643691B2 (ja) * 1998-02-05 2005-04-27 株式会社ノエビア 皮膚外用剤
JP4762383B2 (ja) * 1998-03-12 2011-08-31 キユーピー株式会社 線維芽細胞増殖剤
FR2781151B1 (fr) * 1998-07-17 2001-11-23 Jean Noel Thorel Produits cosmetiques ou dermo-pharmaceutiques, d'origine laitiere
JP3907856B2 (ja) * 1998-11-17 2007-04-18 株式会社ナリス化粧品 化粧料
JP2000178165A (ja) * 1998-12-16 2000-06-27 Shiseido Co Ltd 皮膚外用剤

Also Published As

Publication number Publication date
JP2004502788A (ja) 2004-01-29
EP1303284B1 (de) 2008-09-10
NZ523533A (en) 2006-09-29
WO2002005828A1 (en) 2002-01-24
EP1303284A4 (de) 2004-05-12
DE60135755D1 (de) 2008-10-23
US7410946B2 (en) 2008-08-12
EP1303284A1 (de) 2003-04-23
AUPQ878600A0 (en) 2000-08-03
US20040081673A1 (en) 2004-04-29
CA2415701A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
ATE407685T1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
TW200509956A (en) Compositions and methods for treatment of rosacea
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
DE60239612D1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
BR0008926A (pt) Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
DE59907752D1 (de) Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
ATE322265T1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
TW200505473A (en) Compositions and methods for treatment of psoriasis
DE60124715D1 (de) Er produktion von beta-endorphin
EP1952799A3 (de) Kosmetische Zubereitung mit Hyaluronsäure und Saponinen zur Behandlung von Hautalterungserscheinungen
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60237039D1 (de) Verfahren zur behandlung von rosacea und telangiectasia
ATE216251T1 (de) Myrteextrakt enthaltendes haarpflegemittel, verfahren zur herstellung und verwendung insbesondere für eine antischuppenbehandlung
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
DE60206280D1 (de) Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia
ATE294582T1 (de) Verwendung von alpha-1-adrenorezeptor- antagonisten zur herstellung eines medikaments für die vorbeugung und die behandlung von krebs
DE69920015D1 (de) Verfahren zur induktion der herstellung von wachstumsfaktoren
DE69622704D1 (de) Pharmazeutische zusammensetzungen zur behandlung von alkoholsucht
ATE492285T1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
ATE448796T1 (de) Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein
DE602004016292D1 (de) Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern
BG105924A (en) Composition for the treatment of psoriasis
Ahmad Nasrollahi et al. Comparative clinical assessment of two nasolabial hyaluronic acid fillers: A double-blind, randomized controlled trial

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties